Abstract. The cytoplasmic domains of integrins provide attachment of these extracellular matrix receptors to the cytoskeleton and play a critical role in integrinmediated signal transduction. In this report we describe the identification, expression, localization, and initial functional characterization of a novel form of 131 integrin, termed 131D. This isoform contains a unique alternatively spliced cytoplasmic domain of 50 amino acids, with the last 24 amino acids encoded by an additional exon. Of these 24 amino acids, 11 are conserved when compared to the 131A isoform, but 13 are unique (Zhidkova, N. I., A. M. Belkin, and R. Mayne. 1995. Biochem. Biophys. Res. Commun. 214:279-285; van der Flier, A., I. Kuikman, C. Baudoin, R. van der Neuf, and A. Sonnenberg. 1995. FEBS Lett. 369:340-344). Using an anti-peptide antibody against the 131D integrin subunit, we demonstrated that the ~ID isoform is synthesized only in skeletal and cardiac muscles, while very low amounts of 131A were detected by immunoblot in striated muscles. Whereas ~IA could not be detected in adult skeletal muscle fibers and cardiomyocytes by immunofluorescence, IMD was localized to the sarcolemma of both cell types. In skeletal muscle, 131D was concentrated in costameres, myotendinous, and neuromuscular junctions. In cardiac muscle this 131 isoform was found in costameres and intercalated discs. 131D was associated with oL7A and ot7B in adult skeletal muscle. In cardiomyocytes of adult heart, et7B was the major partner for the B1D isoform. [31D could not be detected in proliferating C2C12 myoblasts, but it appeared immediately after myoblast fusion and its amount continued to rise during myotube growth and maturation. In contrast, expression of the [31A isoform was downregulated during myodifferentiation in culture and it was completely displaced by 131D in mature differentiated myotubes.
concentrated in costameres, myotendinous, and neuromuscular junctions. In cardiac muscle this 131 isoform was found in costameres and intercalated discs. 131D was associated with oL7A and ot7B in adult skeletal muscle. In cardiomyocytes of adult heart, et7B was the major partner for the B1D isoform. [31D could not be detected in proliferating C2C12 myoblasts, but it appeared immediately after myoblast fusion and its amount continued to rise during myotube growth and maturation. In contrast, expression of the [31A isoform was downregulated during myodifferentiation in culture and it was completely displaced by 131D in mature differentiated myotubes.
We also analyzed some functional properties of the [MD integrin subunit. Expression of human 131D in CHO cells led to its localization at focal adhesions. Clustering of this integrin isoform on the cell surface stimulated tyrosine phosphorylation of pp125 FAK (focal adhesion kinase) and caused transient activation of mitogen-activated protein (MAP) kinases. These data indicate that 131D and 131A integrin isoforms are functionally similar with regard to integrin-mediated signaling.
I
NTEGRINS are a large family of transmembrane heterodimeric receptors mediating association between the extracellular matrix (ECM) 1 and cytoskeletal elements (Hynes, 1992; Schwartz, 1992; Juliano and Haskill, 1993; Clark and Brugge, 1995) . Integrins play a crucial role in cell adhesion including cell-matrix and intercellular interactions and therefore are involved in various biological phenomena, including cell migration, differentiation, tissue repair and remodeling, programmed cell death, etc.
grin dimers, capable of interacting with various extracellular matrix molecules as well as some cell adhesion molecules (Hynes, 1992) .
In contrast to the a subunit cytoplasmic domains, which are quite divergent, most B subunits, particularly B1 and B3 subunits, share significant homology within their cytoplasmic tails (Tamkun et al., 1986; Argraves et al., 1987; Fitzgerald et al., 1987) . Cytoplasmic domains of several integrin B subunits, including B1, B3, B5, and 136 associate with the actin cytoskeleton and are required for the recruitment of integrins to focal adhesions of cultured cells (Sastry and Horwitz, 1993; Hemler et al., 1994) . Results of in vitro experiments showed that at least two major actinassociated proteins present at focal adhesions, talin and et-actinin, are capable of interacting directly with B1 integrin intracellular domain peptides Tapley et al., 1989; Otey et al., 1990 Otey et al., , 1993 . Integrin-mediated cell-matrix interaction during the adhesion process induces tyrosine phosphorylation of pp125 FAK and paxillin (Guan et al., 1991; Kornberg et al., 1991 Kornberg et al., , 1992 Burridge et al., 1992; Guan and Shalloway, 1992; Schaller et al., 1992) . Clustering of integrins in the plasma membrane with extracellular matrix ligands or anti-integrin antibodies triggers association of some cytoskeletal proteins, including talin, vinculin, ot-actinin, tensin, paxillin, and zyxin with integrins and leads to nucleation of assembly of actin filament bundles at sites of cell-matrix adhesion (Lewis and Schwartz, 1995; Miyamoto et al., 1995) . Concomitantly, a number of signaling molecules like pp125 FAK, PKC~/, PI-3K, and G protein 7 subunit accumulate at focal adhesions after integrin engagement and activate a variety of signaling pathways within the cell (Clark and Brugge, 1995) . Mutants of the B1 integrin cytoplasmic domain are unable to localize to focal adhesion sites (Marcantonio and Hynes, 1990; Reszka et al., 1992; Akiyama et al., 1994) . The cytoplasmic domain mutants as well as autonomously expressed cytoplasmic domain of B1 subunit were shown to have a dominant-negative effect on cell adhesion and inhibit outside-in signal transduction of integrins Lukashev et al., 1994; Smilenov et al., 1994) . Growing data on 133 integrin subunit cytoplasmic domain mutants also indicate a role for both the entire cytoplasmic domain and some particular amino acid motifs within it for inside-out integrin signaling and regulation of the affinity state and ligand-binding properties of the receptor O'Toole et al., 1994 O'Toole et al., , 1995 .
Recently, two novel isoforms of the [31 integrin subunit were described with altered cytoplasmic domains. One of them, B1B, is an isoform in which the 26-membrane-proximal amino acids of the cytoplasmic domain, encoded by exon 6 of the B1 integrin gene, are retained and then followed by 12 amino acids derived from the intron sequence located adjacent to exon 6 (Altruda et al., 1990) . This is a rather minor isoform and is coexpressed with B1A in some tissues and cells (Balzac et al., 1993) . Upon transfection into cultured cells, B1B serves as a dominant negative integrin variant, inhibiting cell adhesion and motility apparently due to its inability to interact with the actin cytoskeleton (Balzac et al., 1993 (Balzac et al., , 1994 . Based on this evidence, it was suggested that the B1B isoform may function as a "deadhesion" integrin receptor during embryogenesis and in some physiological situations in adult tissues (Balzac et al., 1994) . A similar isoform of the cytoplasmic domain was also described earlier for the B3 integrin subunit (van Kuppevelt et al., 1989) . Another B1 integrin isoform with an alternatively spliced cytoplasmic domain, B1C, was identified in megakaryocytes, platelets and some other blood cells (Languino and Ruoslahti, 1992) . Its cytoplasmic domain consists of 26 amino acids encoded by exon 6 and 48 novel amino acids derived from an additional exon of the B1 integrin gene. Upon transient transfection into mouse 10T1/2 fibroblasts, B1C integrin isoform does not localize to focal adhesions and at moderate concentrations has no effect on actin stress fibers and focal adhesions. However, B1C expression markedly inhibits DNA synthesis and causes growth arrest at the late G1 phase of the cell cycle (Meredith et al., 1995) .
In this report, we describe intracellular localization, expression during myodifferentiation, interaction with et subunits, and some signaling properties of a B1 integrin isoform, termed BID, which has an alternatively spliced cytoplasmic domain, where the 24 most COOH-terminal amino acids are encoded by a novel exon of the B1 integrin gene (Zhidkova et al., 1995; van der Flier et al., 1995) . This fourth variant of B1 integrin appears to be a muscle-specific isoform, replacing the common B1A isoform in terminally differentiated striated muscles. The B1D isoform localizes at various adhesive structures of muscle cells which were thought to contain BIA and is associated primarily with a7 subunit variants. We also show in CHO cells transfected with full-length B1D cDNA that the exogenous muscle-specific B1D subunit is localized to focal adhesions of nonmuscle cells and that antibody-induced clustering of BID integrin causes an increase in tyrosine phosphorylation of pp125 FAK and leads to a transient activation of MAP kinases.
Materials and Methods

Sources of Cells and Tissues
C2C12 mouse skeletal myoblasts were obtained from American Type Culture Collection (ATCC CRL-1772, Rockville, MD) and cultured in Dulbecco's modified Eagle's medium with 10% fetal bovine serum. To switch cells to myodifferentiation, fetal bovine serum was replaced with 3% horse serum in the growth medium. Cells were cultured on plastic dishes coated with 0.1% gelatin. CHO cells were obtained from ATCC and cultured in HAM's F12 medium plus 10% fetal bovine serum. All culture media and supplements were from GIBCO BRL (Gaithersburg, MD). Mouse tissues were dissected without dissociation into individual cells. Mouse and chicken skeletal muscle samples were taken from adult animals.
Isolation of RNA and First Strand cDNA Synthesis
Total RNA from C2C12 cells was obtained by the RNAzolTMB method (Biotecx Laboratories, Inc., Houston, TX) and poly(A)-rich RNA selected by using the polyATract System IV (Promega Corp., Madison, WI) or FastTrack mRNA isolation kit (Invitrogen Corp., San Diego, CA). Synthesis of first strand cDNAs was based on a kit (Reverse Transcription System; Promega Corp.) using 2-5 Ixg of poly(A)-rich RNA in 50 p,l of buffer. A mixture of random primers (10 ~1) was added and the mixture incubated at 65°C and rapidly cooled on ice (1 min). To the RNA/primer mixture, 5 p~l of 100 mM methylmercuric hydroxide (Alpha/Johnson Matthey, Ward Hill, MA) was added with incubation for 10 rain at room temperature followed by 5 p,l of 700 mM 13-mercaptoethanol and incubation for 5 rain at room temperature. For first strand cDNA synthesis, avian myeloblastosis virus reverse transcriptase (Promega Corp.) was employed with incubation at 45°C for 45 rain followed by 55°C for 15 rain. The cDNAs were precipitated with ethanol and resuspended in 50 txl of water.
Polymerase Chain Reaction (PCR)
Synthesized cDNAs were used as a template in the amplification by PCR in a Programmable Thermal Controller (MJ Research Inc., Watertown, MA) . In order to analyze the cytoplasmic domain of mouse 131 integrin, PCR was performed with primers NZ1 (5'-2197TrGTGGAGACTC -CAGACTGTCCTACT2222-3 ') and PE6 (5'-25°cTCAIq"ITCCCTCATACTrCGGATT2477-3'), designed from Argraves et al., 1987; Holers et al., 1989 ; using PCR buffers and Taq 1 polymerase (Perkin Elmer, Norwalk, CT). The cycle parameters were: denaturation at 94°C for 2 rain, annealing at 58°C for 1.5 min, extension at 72°C for 3 rain for 33 cycles with 5 min final elongation at 75°C.
DNA Sequencing
All sequencing was performed on both strands with Sequcnase TM version 2.0 DNA sequencing kit. (U.S. Biochem. Corp., Cleveland, OH). All plasmid templates for sequencing were isolated using the Wizard TM miniprep DNA purification system (Promega Corp.).
Antibodies
Rabbit polyclonal anti-peptide antibody against the last 12 amino acids (CITVVNPKYEGK) of [MA integrin, which is isoform-specific and does not crossreact with either 131D or other known 131 subunit variants, was described and characterized earlier (Balzac et al., 1993 (Balzac et al., , 1994 . Rabbit polyclonal antibodies against synthetic peptides derived from the COOHterminal sequences of ctl, ct2, u3, ~4, c~5, and aV integrin subunits were generated as described previously (Defilippi et al., 1992) . These anti-peptide antibodies were purified by affinity chromatography on the relevant peptides coupled to Scpharose resin. They showed a broad cross-species reactivity. Antibodies to the COOH-terminal sequences of a7A and cOB were a kind gift from Dr. Ginetta Collo (Glaxo, Geneva, Switzerland). 7F9 monoclonal antibody against vinculin was described earlier (Ginkhova et al., 1990) . Anti-phosphotyrosine mAb PY20 was purchased from Transduction Laboratories (Lexington, KY). Anti-MAP kinase rabbit polyclonal antibodies sc-93 and sc-94 were from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit polyclonal antibody N681 against human platelet talin was characterized earlier (Fath et al., 1989) . Rat mAb M1.2 against an extracellular epitope of mouse 131 integrin was a kind gift of Dr. B. Chen (University of Western Ontario, London, Ontario, Canada). mAb TS2/16 against human integrin 131 subunit was a gift from Dr. F. Sanchez-Madrid (Hospital de la Princesa, Madrid, Spain). Rabbit antiserum 5158 against COOH-terminal portion of pp125 FAz was kindly provided by Dr. L Romer (University of North Carolina, Chapel Hill).
Generation of Antibody against fllD Integrin Subunit
Three integrin cytoplasmic domain peptides were synthesized at the Peptide Synthesis Facility of the Department of Chemistry, University of North Carolina, Chapel Hill. A 48-mer CKLLMIIHDRREFAKFEKEK-MNAKWDTGENPIYKSAVITVVNPKYEGK corresponded to the amino acid sequence of integrin 131A whole cytoplasmic domain. A second peptide was a 51-met CKLLMIIHDRREFAKFEKEKMNAKWDTQENPI-YKSPINNFKNPNYGRKAGL, which represented the entire cytoplasmic domain sequence of the novel 131D integrin subunit. The third peptide was a 17-met CPINNFKNPNYGRKAGL, which contained an amino acid sequence present only in the 131D isoform, and not in 131A isoform. An NH 2-terminal cysteine, was added to all peptides to orient peptide coupling to either carrier protein keyhole limpet hemocyanin or to the activated resin thiopropyl Sepharose 6B (Pharmacia-Biotech., Uppsala, Sweden). The 51-mer corresponding to the whole cytoplasmic sequence of 131D was conjugated to Imject TM maleimide-activated keyhole limpet hemocyanin (Pierce, Rockford, IL) at a ratio of ~50-100 mol of peptide to 1 tool of the protein. Rabbits were immunized subcutaneously with i mg of this conjugate in complete Freund's adjuvant (GIBCO BRL) and boosted 5 wk later with 0.5 mg of this conjugate in incomplete Freund's adjuvant (GIBCO BRL). Boosts were repeated every 4 wk with 0.5 mg of the conjugate. Serum was collected which gave some positive reaction in immunoblotting of extracts of muscle tissues. Both a 48-mer representing the whole cytoplasmic domain of 131A subunit and a 17-mer, containing the new amino acid sequence specific for 131D subunit, were coupled to thiopropyl Sepharose 6B according to the manufacturer's instructions. Pooled antiserum was preadsorbed first with immobilized 131A integrin cytoplasmic domain peptide and the unbound material was loaded onto a column containing immobilized 17-mer, representing the new sequence of 131D integrin isoform. The column was extensively washed with 50 mM Tris-HCl, 1.5 M NaCI, pH 7.5, and bound material was eluted with 200 mM Glycine adjusted to pH 2.2 with HCI. The pH of the column eluate was immediately readjusted to pH 8.0 with 1 M "Iris, and the affinity-purified IgG fraction was extensively dialyzed against 0.1 M NaaBO4, 150 mM NaCI, pH 8.1, and stored at 4°C in the presence of 2% BSA.
lmmunoprecipitation, Electrophoresis, and lmmunoblotting of iliA and fllD Integrins
For immunoprecipitation, various adult mouse tissues were homogenized and boiled in 1% SDS, tissue extracts were spun down and supernatants were diluted with 1% Triton X-100 in 50 mM Tris-HCl, 150 mM NaCl, pH 7.5, to give a final SDS concentration of 0.1%. Protein concentration was determined in tissue extracts using Micro BCA Protein Assay Reagent Kit (Pierce) and samples containing Img of total protein were taken for subsequent immunoprecipitation with antibodies. Ceil and tissue lysates were subjected to immunoprecipitation with either anti-131A or anti-131D integrin antibodies (~5-10 p,g of affinity-purified anti-131A or anti-131D IgG were used per one sample), followed by protein A-Sepharose beads. Both incubations were done at 4°C on the rotator. Beads were extensively washed with 1% Triton X-100 in 50 mM Tris-HC1, 150 mM NaCl, pH 7.5, and immunoprecipitates were boiled in electrophoresis SDS sample buffer. For electrophoresis, 10% polyacrylamide gels, containing 0.13% hisacrylamide, were used (Laemmli, 1970) . Proteins were transferred onto Immobilon Membranes (Millipore, Bedford, MA) as described by Towbin et al. (1979) . Blots were blocked with 2% BSA, 2% cold water fish gelatin, 0.1% Tween 20 in TBS (50 mM Tris-HCl, 150 mM NaCI, pH 7.5) for 1 h. Then blots were incubated with 0.5 }xg/ml of anti-131A or anti-131D IgG. Goat anti-rabbit affinity-purified IgG, conjugated with peroxidase (Jackson Immunoresearch, West Grove, PA), diluted 1:10,000, was used as the secondary antibody. Blots were extensively washed with TBS plus 0.1% Tween 20, then with TBS and finally developed using ECL reagents (Amersham, Arlington Heights, IL).
To study the expression patterns of 131D and 131A during myodifferentiation in culture, C2C12 cells, taken on day 1 to day 9 after plating, were lysed in 1% SDS. 0.5 mg of total cellular protein was taken for immunoprecipitation using the method described above. To separate myotubes from the remaining myoblasts in culture for the analysis of 131D and 131A content in both cell populations, C2C12 mixed myoblast/myotube cultures were treated first with 0.01% trypsin, 0.004% EDTA for 15 min. Under these conditions myotubes slowly detached from the substrate, whereas 0.05% trypsin and 0.02% EDTA was needed to deadhere remaining myoblasts.
Constructs and Transfections
The eDNA for the 131D isoform was prepared from the human 131B eDNA in the pECE vector (Balzac et al., 1994) . The Hind III site in the polylinker of the vector was removed and the sequence encoding the cytoplasmic region of 131B between the two Hind III sites (positions 2250 and 2742, respectively, starting from the ATG) was then replaced with the new sequence specific for the 131D variant. The DNA fragment corresponding to the 131D specific sequence was prepared by PCR amplification using mouse eDNA as a template. The PCR primers included Hind III sites for cloning into the vector.
Stable transfectants of CHO cells expressing the human integrin 131A or 131D were obtained as described previously (Balzac et al., 1993 (Balzac et al., , 1994 . Briefly, a 3.5-kb EcoRI fragment of the 131D integrin containing the entire coding sequence was inserted into the EcoRI-cloning site of the SV40-based expression vector pECE (Ellis et al., 1986) . The full-length cDNA for the human [31A integrin cloned in the pECE vector was a kind gift of Dr. Filippo Giancotti (Giancotti and Ruoslahti, 1990) . CHO cells were cotransfected with 20 p,g of the plasmid containing either 131A or 131D eDNA and 2 mg of pSV2-neo (Southern and Berg, 1982) , and neomycinresistant clones were selected in Ham's F12 medium with 10% FCS and 800 ixg/ml of G418 (GIBCO BRL). Cells expressing the transfected protein were selected by plating on a dish coated with 50 ~g/ml of mAb BV7 reacting with an extracellular epitope of the human 131 integrin (MartinPadura et al., 1994) . Adherent cells were grown and subjected to repeated cycles of selection on the antibody until the appropriate expression level was achieved. Flow cytometry analysis of the transfectants was performed as described earlier (Balzac et al., 1994) .
Adhesion Experiments with [~IA-and ~ I D-Transf ectants
CHO transfectants were kept in serum-free Ham's F12 medium for ~3 h before their detachment. Confluent cells were de-adhered from culture flasks with 0.05% trypsin, 0.53 mM EDTA and turkey egg trypsin inhibitor (Sigma) was immediately added to the cell suspension up to a final concentration of 0.5 mg/ml. The suspended cells were washed twice with Ham's F12 medium plus 2% BSA and cell suspensions were incubated for 1 h at 37°C on the rotator. For plating experiments, T25 tissue culture flasks were precoated with mAb TS2/16 against human IM integrin, at a concentration of 10 p.g/ml, as described earlier (Balzac et al., 1994) .
2307.. attgtagcaggcgtggt tgc t g g a a~g t t et tart ggcc~t ~IA 732.. To examine tyrosine phosphorylation of pp125 FAK upon adhesion of CHO transfectants on TS2/16 mAb, plated cells, taken at various timepoints (15, 30, 60, and 150 rain) and cells kept in suspension, were rinsed twice with PBS and lysed with buffer, containing 50 mM Tris-HCl, pH 7.5, 150 mM NaC1, 1% Triton X-100, 0.5% Na deoxycholate, 0.1% SDS, 1 mM Na orthovanadate, 10 ~g/ml leupeptin, and 10 p~g/ml pepstatin, i ml of lysis buffer was used for each T25 tissue culture flasks. Cell lysates were precleared by centrifugation (10,000 rpm, 15 min, 4°C). Protein content in cell lysates was determined using Coomassie Protein Assay Reagent (Pierce) and 1 mg of total cellular protein was taken for immunoprecipitation. Rabbit antiserum 5158 against pp125 FAK (5 p~l per sample) and protein A-Sepharose were used to precipitate pp125 F~ac from cell lysates. The resulting immunoprecipitates were washed five times with lysis buffer, once with PBS and finally boiled in SDS sample buffer for electrophoresis. Samples were loaded on 10% gels and blots were probed with PY20 mAb (1 txg/ml) followed by goat anti-mouse afffinity-purified IgG, conjugated to peroxidase (Jackson) taken at 1:10,000 dilution.
To study activation of MAP kinases by gel mobility shift assay in response to CHO cell attachment and spreading via either 131A or 131D integrins, CHO transfectants were plated on TS2/16 mAb as described above. Cells kept in suspension or plated on the antibody-coated surfaces for 30, 90, or 200 min, were rinsed with PBS and cells lysed with 2% SDS plus 1 mM Na orthovanadate (200 p,l of lysis buffer per each T25 flask or pellet of suspended cells) and cell lysates were immediately boiled for 5 min. Protein content in different samples was equalized and 50 p,g of total cellular protein was loaded onto each gel lane. Electrophoresis on 15% polyacrylamide gel was used to improve the resolution of MAP kinase bands.
Polyclonal antibody sc-94, reacting with both MAPK1 and MAPK2 kinases (1:1,000 dilution) was used in combination with secondary goat antirabbit affinity-purified IgG (Jackson, diluted 1:10,000) for visualization of MAP kinase bands on the blot.
To analyze activation of MAP kinases by immune complex kinase activity assay in CHO cells transfected with 131A and 131D integfins, cells were kept in suspension or plated on TS2/16 mAb-coated dishes for 15, 30, 45, or 150 min. Cells were lysed with 1 ml of buffer, containing 150 mM NaCI, 1% Nonidet P-40, 0.5% Na-deoxycholate, 50 mM Hepes, pH 7.5, 1 mM Na orthovanadate, 50 mM NaF, 1 mM p-nitrophenyl phosphate, 20 nM calyculin A, 10 p~g/ml aprotinin, 10 p~g/ml leupeptin, and 1 raM phenylmethylsulfonyl fluoride. Protein content in various samples was equalized using Coomassie Protein Assay Reagent (Pierce) and 0.5 mg of total cellular protein was taken for immunoprecipitation. MAP kinases were immunoprecipitated using sc-93 rabbit antibody (1 p.g per sample) followed by protein A-Sepharose. Immune complexes were washed four times with the lysis buffer, twice with 0.25 M Tris-HCl, pH 7.6, and once with 0.1 M NaCI, 50 mM Hepes, pH 8.0. The immunoprecipitated MAP kinases were incubated with 100 ml of a mixture, containing 1 p.Ci of ['y32p]ATP, 50 p,M ATP, 10 mM MgCI2, 1 mM dithiothreitol, 1 mM benzamidine, 0.3 mg/ml myelin basic protein (MBP), and 25 mM Hepes, pH 8.0, at 30°C for 20 rain. The reaction was stopped by boiling supernatants in SDS sample buffer. 10 p,g of MBP was loaded on a 15% polyacrylamide gel. Proteins were fixed, stained with Coomassie Brilliant Blue and the gel was dried and exposed to Kodak x-ray Film for visualization of phosphorylated MBP bands.
I m m u n o f l u o r e s c e n c e
For immunofluorescent staining of skeletal and cardiac muscle sections, 5-7 ixm cryosections of mouse or chicken adult muscle tissues were fixed for 10 min with ice-cold acetone. Cryosections were blocked with 2% BSA in PBS and then incubated with 10 p,g/ml of either anti-131A or anti-131D IgG. Affinity-purified goat anti-rabbit IgG, coupled with Texas Red (Chemicon, Temecula, CA), taken at 1:40 dilution, was used as secondary antibody. Localization of 131D and 131A in mouse adult skeletal and cardiac muscle tissues was also compared with the distribution of vinculin, visualized with 7F9 mAb. In this case, a mixture of donkey anti-rabbit IgG, conjugated with Texas Red (Chemicon, 1:40 dilution), and donkey antimouse IgG, conjugated with fluorescein (Chemicon, 1:40 dilution), was used as both secondary antibodies for simultaneous visualization of antigens. To visualize 131D or 131A integrins at neuromuscular junctions, chicken skeletal muscle tissue sections were double stained using fluorescein-conjugated goat anti-rabbit IgG in combination with rhodamine-conjugated a-bungarotoxin (Molecular Probes, Eugene, OR). Adult chicken skeletal muscle tissue sections, containing myotendinous junctions were double-stained with anti-131D or anti-131A variant-specific antibodies followed by fluorescein-conjugated goat anti-rabbit IgG (1:40 dilution) and 7F9 mAb against vinculin followed by rhodamine-conjugated donkey anti-mouse IgG (1:40 dilution).
To study localization of 131D in differentiating C2C12 myocytes by immunofluorescence, C2C12 cells, growing on laminin-coated coverslips, were taken at various timepoints of myodifferentiation, fixed with ice-cold methanol and stained with 10 p,g/ml of anti-131D antibody, followed by goat anti-rabbit IgG, conjugated with Texas Red (1:40 dilution).
For immunofiuorescent staining of 131A-and 131D-expressing CHO transfectants, cells cultured in Ham's F12 medium with 10% FCS, were detached with trypsin and then replated on fibronectin-precoated glass coverslips for 3 h. Cells were fixed with 3.7% formaldehyde in PBS for 10 min and permeabilized with 0.5% Triton X-100 in PBS for 2 min. For double-staining of 131A-and 131D-CHO transfectants, TS2/16 inAb against human 131 integrin was used in combination with rabbit polyclonal antitalin antibody. A mixture of donkey anti-mouse IgG conjugated with rhodamine (1:40 dilution) and donkey anti-rabbit IgG coupled with fluorescein (1:40 dilution), was used for both secondary antibodies.
Analysis of fllD Association with a Subunits
Frozen mouse skeletal and cardiac muscle tissues were triturated in liquid nitrogen, extracted and sonicated at 4°C in 0.5% Triton X-100 in 20 mM Tris-HCl, pH 7.4, 150 mM NaCI, I mM CaCl 2, I mM MgC12, 10 p,g/ml leupeptin, 4 p,g/ml pepstatin, and 0.1 TIU/ml aprotinin. After centrifugation at 10,000 g for 10 rain, extracts were preincubated with nonimmune rabbit IgG, coupled to Sepharose for removing the material that nonspecifically binds Sepharose. Integrin complexes were immunoprecipitated by incubating with the specific antibodies to alpha subunits for 15 h at 4°C with gentle agitation, followed by I h incubation with protein A-Sepharose beads (Pharmacia). After extensive washing, bound material was eluted by boiling the beads in SDS sample buffer with or without 13-mercaptoethanol respectively for immunoblotting with either 131D antibody or rat M1.2 mAb against mouse 131 integin subunit. Proteins were run on a 6% SDS-polyacrylamide gel, transferred to nitrocellulose and probed with either anti-BID antibody (0.5 i~g/ml) or with 0.2 ixg/ml of the rat mAb M1.2 to the mouse 131 integrin subunit. Peroxidase-conjugated anti-rabbit IgG (Sigma, Italy) or peroxidase-conjugated anti-rat IgG (Boehringer Mannheim Corp., Mannheim, Germany) were used as secondary antibodies.
Results
Identification and Amino Acid Sequence of Mouse fllD Integrin Cytoplasmic Domain Isoform
In preliminary experiments, it was observed that a polyclonal anti-peptide antibody to the cytoplasmic domain of [31 integrin (Marcantonio and Hynes, 1988) failed to give immunofluorescent staining of the sarcolemma of adult skeletal and cardiac muscles (A. M. Belkin, N. I. Zhidkova and V. E. Koteliansky, unpublished observations). However, polyclonal or monoclonal antibodies to the extracellular domain of [31 integrin always gave strong immunofluorescent staining of the surface of adult striated muscle cells (Bozyczko et al., 1989; Swasdison and Mayne, 1989) . These observations first suggested the possibility that an isoform of the cytoplasmic domain of [31 integrin might displace the ubiquitously expressed [31A isoform in muscle cells. To examine this possibility, reverse transcription polymerase chain reaction (RT-PCR) reactions were performed using RNA preparations obtained from C2C12 cells taken at various timepoints of myodifferentiation and 24-mer antisense oligonucleotides NZ1 and PE6 that span the portion of [31 integrin subunit mRNA encoding transmembrane and cytoplasmic domains. At early timepoints preceeding cell fusion in myogenic culture, only one band most likely corresponding to the [31A isoform was detected ( Fig. 1 A, lanes 1 and 2) . However, after cell fusion occurs in C2C12 culture and myotubes grow and differentiate, a prominent upper band was detected together with the original lower band (Fig. 1 A, lanes 3 and 4) . Each band was subcloned into the P C R~I I vector and subjected to nucleotide sequencing (Fig. 1 B) . The results showed that the lower band had an identical nucleotide sequence to the published sequence for the mouse B1A iso- form (Holers et al., 1989) . However, the upper PCR-gencrated band contained an additional 81-bp insert with an open reading frame for 72 bp after the stop codon. The position of the 81-bp insert, encoded by a novel exon of the 131 integrin gene coincided with the boundary between exons 6 and 7 of the gene (Lanza et al., 1990) where all the diversity of previous 131 integrin cytoplasmic domain isoforms was shown to be generated by differential splicing (Altruda et al., 1990; Languino and Ruoslahti, 1992) . The deduced amino acid sequence differed markedly from the previously described 131B and 131C isoforms and this newly identified 131 integrin variant was therefore assigned f31D. Fig. 1 C shows the comparison of 131D integrin with all other known cytoplasmic domain isoforms. Notably, the COOH-terminal parts of 131A and 131D cytoplasmic domain variants, unlike the alternatively spliced amino acid sequences of 131B and 131C, share 11 amino acids in common, including two conserved NPXY motifs at the same positions ( Fig. 1 C, underlined) . The amino acid sequence for mouse 131D was identical to the recently reported chicken and human 131D sequences (Zhidkova et al., 1995) .
The [31D lntegrin Isoform Is the Predominant [31 Integrin lsoform Expressed in Skeletal and Cardiac Muscles
Using an anti-peptide antibody specific for the 131D sequence, we examined the expression pattern of this integrin in various tissues of adult mouse by immunoprecipitation and subsequent immunoblotting and compared it to that of 131A isoform. Significant amount of 131D integrin, represented by a broad band with a Mr around 140 kD was found in two different types of skeletal muscle (Fig. 2 A, a  and b) . In heart muscle extracts a slightly slower migrating band of f31D was detected (Fig. 2 A, c) . The 131D isoform was not detected in any other tissues analyzed except for a very weak reaction in skin. This may be explained by a trace contamination of this sample with skeletal muscle cells. In contrast, the 131A isoform was detected in all the tissue samples analyzed, but with slightly weaker reaction in cardiac muscle and notably fainter bands in the two skeletal muscle samples analyzed (Fig. 2 B) . These data indicated that 131D is the predominant 131 integrin variant in adult striated muscles.
Localization of 131D and [31A Integrin Isoforms in Adult Skeletal and Cardiac Muscles
Double immunostaining of transverse sections of skeletal muscle with antibodies against the 131D integrin variant and vinculin showed that 131D was localized at the sarcolemma of skeletal muscle fibers (Fig. 3 A, arrows) . Some nonmuscle cells, present in the skeletal muscle tissue, were positive for vinculin but did not express any 131D (Fig. 3, A and B, arrowheads). In contrast, the 131A integrin isoform was virtually undetectable at the sarcolemma, but was clearly visualized in some connective tissue and capillary cells of the tissue (Fig. 3, C and D, arrows, 
arrowheads).
Detailed analysis of the intracellular localization of the 131D isoform in skeletal muscle showed that this integrin subunit is accumulated at all major adherens-type junctions of skeletal muscle fibers (Fig. 4) . Double-labeling with ~x-bungarotoxin revealed the presence of 131D integrin at neuromuscular junctions (Fig. 4, A and B, arrows) .
[31D was also localized at skeletal muscle fiber costameres (Fig. 4 C) . Finally, a very intense staining of the myotendinous junction was obtained with anti-131D antibody, showing that 131D is particularly enriched at these cell-matrix junctional sites (Fig. 4, D and E) . The 131A integrin isoform was not identified at any of these junctional structures (data not presented).
In cardiac muscle, the 131D integrin isoform was prominent at the sarcolemma of cardiomyocytes and codistributed with vinculin (Fig. 5, A and B, arrows) . Although abundantly expressed in nonmuscle ceils present in this tissue, the 131A integrin subunit was not detected at the sarcolemma (Fig. 5 C, arrowheads) . With longitudinal sections of cardiac muscle, we could detect 131D integrin staining at both costameres and intercalated discs, two major adherens-type junctions of cardiomyocytes (Fig. 5 D) which also contain vinculin (Fig. 5 E) . Again, the 131A integrin variant was not localized at these two types of junctional structures in cardiac muscle (Fig. 5 F) .
Association of fllD with a7 Subunit Isoforms In Vivo
Western blot analysis with a panel of antibodies specific Figure 6 . Association of 131D integrin isoform with integrin subunits in adult mouse skeletal and cardiac muscles. Mouse muscle tissues were extracted under conditions favoring association of a and 13 subunits and integrin complexes were immunoprecipitated with antibodies specific for ~3, a5, c~V, ~x7A, and c~7B integrin subunits. After electrophoresis and electrotransfer, co-precipitated 131 integrin isoforms were visualized on immunoblots by reacting with antibodies specific to the 131D isoform (top) or antibody to an extracellular epitope, common to all four known 131 integrin isoforms. Note that 131D was detected in association only with a7B subunit in heart muscle and in skeletal muscle 131D is associated with a7A and a7B.
for ct subunits indicated that c~3, ct5, ctV, et7A, and tx7B were the major integrin et subunits expressed in adult skeletal muscle (data not shown). In adult heart muscle a similar pattern of c~ subunits was detected except that a7A was absent (Fig. 6, bottom) , confirming previous report (Collo et al., 1993) . To assess which (x subunit was associated with 131D integrin, tissue extracts were immunoprecipitated with various antibodies against ~x subunits and immunoprecipitates were probed by immunoblotting with anti-131D antibody or an anti-B1 mAb reacting with all known 131 isoforms. As shown in Fig. 6 , 131D integrin appeared to be associated exclusively with ct7A and a7B subunit variants in skeletal muscle, whereas in cardiac muscle a7B was the major pairing partner for the 131D. e~3 and tx5 subunits which are known to be expressed in the connective tissue and blood vessels present in muscle tissues, are associated with a different [31 isoform, probably 131A, since there was a prominent reaction in immunoblot of anti-~3 and anti-~5 immunoprecipitates with anti-131 antibody (Fig. 6) . Only a very minor portion of 131 was found associated with aV in adult muscle tissues.
Expression and Localization of BID Integrin during Myodifferentiation
During myodifferentiation of mouse C2CI2 cells in culture, 131D could not be detected in replicating myoblasts (Fig. 7 A, a and b) . Immediately after cell fusion occurred, a 131D band was detectable (Fig. 7 A, c) . Thereafter, the amount of 131D continued to increase reaching its highest level at day 9 through day 10, when mature differentiated myotubes appear in the cell culture (Fig. 7 A, d and e) . In contrast, large amounts of 131A isoform were found in prefusion myoblasts (Fig. 7 B, a and b) . A significant decrease in the content of 131A acccompanied subsequent stages of myodifferentiation after cell fusion, and only a weak 131A band was seen at late timepoints in C2C12 culture (Fig. 7 
B, c-e).
Upon the separation of myotubes and myoblasts in culture on day 6 after plating, we found that 131D was abundantly expressed in growing myotubes but was absent from postmitotic myoblasts (Fig. 7 C, a and b) . In contrast, comparable levels of 131A expression in myoblasts and differentiating myotubes were found at this timepoint of myodifferentiation (Fig. 7 C, a'b' ).
By immunofluorescence, we also did not see any [31D in C2C12 myoblasts except for some distinct perinuclear staining. This most likely corresponded to [31D accumulation in the Golgi apparatus (Fig. 8 A, arrows) . As cell fusion occurred in culture, early myotubes having 2-4 nuclei displayed bright regions of [31D immunostaining, with clear accumulation of the protein at focal adhesions in myotube tips (Fig. 8 B, long arrow, arrowheads) . In larger, more mature myotubes, 131D appeared to accumulate at focal adhesions located throughout the entire ventral surface of the myotubes (Fig. 8 C, arrowheads) . A fibrillar pattern of 131D on the dorsal surface of branching myotubes suggested codistribution with ECM fibrils (Fig. 8 D) . Finally, 131D integrin was found redistributed to costameres of terminally differentiated contractile myotubes (Fig. 8 E, arrows) .
r i D is Localized to Focal Adhesions in Transfected CHO Cells
CHO cells were transfected with plasmids encoding fulllength human 131A and 131D isoforms of the [31 integrin subunit. As determined by FACS analysis of 131A integrinand 131D integrin-transfected CHO cells, these cell lines expressed comparable amounts of transfected integrin subunits on their surface (Table I) . To analyze the intracellular localization of [31D in transfected CHO cells, we performed double immunofluorescent staining of these cells with TS2/16 mAb, which is specific for the extracellular domain of human integrin 131 subunits, and polyclonal anti-talin antibodies. Immunofluorescent staining showed that 131D integrin is specifically accumulated at focal adhesions of CHO cells plated on fibronectin and is codistributed with talin at these sites (Fig. 9, C and D) . The pattern for transfected 131D integrin subunit in these cells was largely indistinguishable from the distribution of transfected 131A (Fig. 9, A and B) . Both 131A-and 131D-CHO transfectants adhered and spread similarly on surfaces coated with anti-human integrin TS2/16 mAb. However, in this case both types of CHO transfectants remained less spread than on a fibronectin substrate, and a somewhat less distinct pattern of 131D and 131A localization in focal adhesions was observed (data not shown).
Adhesion via fllD Integrin Causes Tyrosine Phosphorylation of pp l25 FAK
We also used 131D-transfected CHO cells in adhesion experiments with TS2/16 mAb-coated culture flasks to determine whether clustering 131D integrin leads to increased tyrosine phosphorylation of pp125 FAR. After plating of the 131D-transfected CHO cells on the antibody substrate, we consistently observed an increase in tyrosine phosphorylation of ~130-kD protein band corresponding to pp125 FAK (Fig. 10 B, arrow) . This was detected as early as 15 min after plating of 131D-CHO transfectants on TS2/16 mAb ( Fig. 10 B, b) . The level of tyrosine phosphorylation of pp125 FAR in 131D-CHO cells significantly increased by 30 min and reached a plateau thereafter (Fig. 10 B, c-e) . A similar time course of pp125 FAK tyrosine phosphorylation was observed with the 131A-CHO transfectants adhering to surfaces coated with the same antibody, except a slightly higher level of pp125 FAK phosphorylation was detected in 131A-CHO cells (Fig. 10 A, a-d) . It should be noted that lower levels of tyrosine phosphorylation of pp125 FAR in 131D-CHO cells at early timepoints of adhesion corresponded to a slower and less efficient spreading of 131D-CHO transfectants compared with the 131A-CHO counterparts (data not shown).
fl lD Integrin-Mediated Adhesion Leads to Activation of MAP Kinases
Activation of MAP kinases upon adhesion of [31A-and 131D-CHO transfectants on TS2/16 mAb was examined first by mobility shift assay as described previously Zhu and Assoian, 1995) . Plating of the 131D-CHO transfectants on anti-integrin antibody caused a distinct electrophoretic mobility shift of both the 42-and 44-kD MAP kinase bands (Fig. 11 B , a and b, arrows, arrowheads) . The observed activation of MAP kinase was transient, peaking at 30 min and had dropped by ~90 min after plating (Fig. 11 B, c and d) . As detected by mobility shift kinase assay, the observed pattern of MAP kinase activation in the case of 131D-mediated adhesion looked identi-
Figure8
. Localization of 131D integrin isoform in differerentiating cultured C2C12 myocytes. C2C12 myocytes were taken on day 3 (A), day 5 (B), day 7 (C), day 9 (D) and day 11 (E) of culture and stained with antibody specific for [31D integrin isoform. Arrows in A mark I31D localization in Golgi apparatus of growth-arrested myoblasts. Long arrow in B points to accumulation of IMD isoform in early myotubes. Arrowheads in B and C indicate localization of 131D at myotube's focal adhesions. Small arrows in E mark presence of [31D integrin at costameres of differentiated contractile myotubes. Bar, 10 ixm.
cal to that seen for 131A-CHO transfectants (Fig. 11 A , arrows, arrowheads) .
To study adhesion-dependent activation of MAP kinase in 131D-CHO and [31A-CHO cells in more detail, we immunoprecipitated MAP kinases and examined their enzymatic activity by immune complex kinase assay using MBP as an exogenous substrate (Fig. 11, C and D) . Again, we demonstrated that MAP kinases underwent transient activation in CHO cells adhered via the [31D integrin isoform. The overall level and time course of adhesion-dependent MAP kinase activation in 131D-CHO transfectants were largely indistinguishable from those observed for 131A-CHO cells.
Discussion
Identification of the fllD Isoform and its Comparison with Other fll lntegrin Cytoplasmic Domain Variants
It is commonly accepted that all adhesion-dependent cell types express one or more 131 integrin heterodimers (Hynes, 1992) . Of the three previously identified cytoplasmic domain variants of 131 integrin, two (131B and 131C) are minor isoforms (Languino and Ruoslahti, 1992; Balzac et al., 1993) , leading to the idea that 131A is the predominant variant in most cells. It was surprising, therefore, that in our preliminary experiments an anti-peptide antibody against the 131A cytoplasmic domain failed to recognize the antigen in either adult skeletal or cardiac muscles, even though antibodies to the extracellular domain of 131 integrin had been reported to stain the sarcolemma brightly (Bozyczko et al., 1989; Swasdison and Mayne, 1989) . This observation has led us to this identification of a fourth cytoplasmic domain variant, [31D, which is specifically expressed in muscle cells. This variant arises through differential splicing of [31 integrin pre-mRNA. Analysis of the exon-intron organization of the human [31 integrin gene shows that the novel amino acid sequence of [MD is encoded by a single additional exon D, located between exons 6 and 7 and upstream from exon C which encodes part of the [31C cytoplasmic domain variant (N. I. Zhidkova et al., 1995) . Recently, similar data were obtained for mouse [31 integrin gene and [31D isoform (A. van der Flier et al., 1995) .
Comparing the four known cytoplasmic domain variants of the [31 integrin subunit (Fig. 1C) indicates that [31D is closest to the widely distributed [31A. In contrast, [31B and [MC are distinct and in the alternatively spliced regions of the cytoplasmic domain they show no homology with [31A (Tamkun et al., 1986; Argraves et al., 1987; Altruda et al., 1990; Languino and Ruoslahti, 1992) . Of the 24 amino acids encoded by the newly identified exon D, 13 are unique, whereas 11 are conserved between [31D and [MA. Notably, are conserved between these two cytoplasmic domain variants.
B1D Integrin Is the Predominant fll Integrin Isoform Expressed in Striated Muscles and Is Localized at Various Adherens-Type Junctions
Analysis of the tissue distribution of the novel 131D integrin isoform showed that on the protein level its expression is strictly limited to skeletal and cardiac muscle tissues. During myodifferentiation of C2C12 myocytes, [31A becomes progressively replaced by 131D. Moreover, the expression and localization of [31D and [31A in adult skeletal and cardiac muscle tissues demonstrate that [MD displaces the common 131A isoform in terminally differentiated muscle cells. Although we cannot say that mature striated muscle cells have no [31A, the level appears to be very low and possibly negligible. Differentiated muscle cells appear, therefore, to be one of the few adherent vertebrate cells that have little or no [31A integrin. [31C is not expressed in adult striated muscles (G. Tarone, personal communication), whereas [31B was only detected in trace amounts in muscle tissues (Balzac et al., 1993) . Together these results suggest that [31D is the predominant [31 integrin variant in striated muscles.
Immunolocalization of [31D integrin in muscle cells revealed its presence in all those junctional structures, including myotendinous junctions and neuromuscular junc- tions of skeletal muscle and costameres of both skeletal and cardiac muscle, that were previously described to contain the 131 integrin subunit (Bozyczko et al., 1989; Swasdison and Mayne, 1989 ). Since we were unable to detect any 131A isoform in terminally differentiated muscle cells by immunostaining, we conclude that all these cell-matrix junctions contain only the 131D integrin variant. Here we also report localization of the 131D integrin isoform at intercalated discs, major cell-cell contact structures of cardiomyocytes. To our knowledge, this is the first demonstration of 131 integrins in intercalated discs. It will be interesting to identify the extracellular ligand for 131D-containing integrins at these sites.
Analysis of the association of 131D integrin with et subunits in vivo showed that among the et subunits analyzed in our experiments, a7B is the only ot subunit complexed with 131D in cardiac muscle, whereas both et7A and et7B variants interact with 131D in skeletal muscle. Cytoplasmic domain structure does not contribute to the specificity of ct/~ subunit association , but the restricted tissue expression for both 131D and et7 integrin subunits and their colocalization in skeletal muscle fibers are striking (Song et al., 1992; Bao et al., 1993) . a7A131D and a7B131D appear to be the major integrin receptors involved in cytoskeletal-matrix interactions of differentiated striated muscles.
Possible Functions of the [31D Integrin Isoform in Muscle Cells
When 131D was expressed in CHO cells, it concentrated in focal adhesions. This distinguishes it from the 131B isoform, which neither targets to focal adhesions nor is detected in adherens-type junctions (Balzac et al., 1993) . The recruitment of 131D to focal adhesions is consistent with the similarity of its cytoplasmic domain to that of 131A and suggests that 131D may interact with some of the same cytoskeletal proteins as 131A. Together, these observations reflect constraints for the overall structure of the 131 integrin cytoplasmic domain with regard to its interaction with the actin cytoskeleton (Marcantonio et al., 1990; LaFlamme et al., 1992 LaFlamme et al., , 1994 Reszka et al., 1992; Pasqualini and Hemler, 1994; Lewis and Schwartz, 1995) . Integrins of the 131A subfamily have been shown not only to have a structural role linking the cytoskeleton to the ECM, but also to be involved in signaling. Transfection of human 131D into CHO cells enabled us to ask whether this integrin is also capable of signaling. Clustering of 131D integrins in these trans-fected CHO cells stimulated tyrosine phosphorylation of pp125 FAK. The response was similar to the tyrosine phosphorylation of pp125 FAK generated as a result of clustering transfected [31A, but less effective, presumably due to slower spreading of 131D-CHO transfectants on anti-[31 integrin antibody, pp125 FAK has been identified at myotendinous junctions (Baker et al., 1994) . Although the function of pp125 FAK at these sites has not been determined, it seems likely that it is associated with [31D. The interaction of [31A integrins with ECM also activates the MAP kinase pathway, possibly as a downstream consequence of pp125 FAK activation Schlaepfer et al., 1994; Zhu and Assoian, 1995) . Again, using the transfected CHO cells, we have shown that 131D is capable of activating MAP kinases and the overall level and time course of this activation were similar for [31D and [31A isoforms. The relevance of this pathway, however, to mature skeletal muscle cells is uncertain, since these cells are withdrawn irreversibly from the cell cycle after myoblast fusion. Also, it should be mentioned, that even though the 131D-and [31A-mediated response looked similar with the high concentration of aggregating antibody, used in these experiments, at lower concentrations of the same antibody, we observed much slower spreading of the [31D-CHO transfectants compared with the 131A-CHO cells. This was accompanied by decreased tyrosine phosphorylation of pp125 FAK and delayed activation of MAP kinases in the case of [31D transfectants (data not shown). These observations suggest that under conditions of nonmuscle environment, 131D may be less effective than 131A with regard to integrin-mediated signaling. In muscle cells, however, one cannot exclude that 131D transmits different or substantially modified signals compared with [31A. This might occur if muscle-specific signaling molecules are expressed that interact with 131D.
Expression of the 131 integrin subunit, as well as the occupation of 131-containing integrin heterodimers is necessary for myodifferentiation and the formation of sarcomeric cytoarchitecture (Menko and Boettiger, 1987; Volk et al., 1990) . Since the majority of [31 integrins are represented by the 131D isoform in differentiated skeletal muscle, the function of [31 integrin during myodifferentiation should be mostly attributed to this novel cytoplasmic domain isoform. A major function for integrins is to transmit tension generated by the actin cytoskeleton across the plasma membrane to the ECM. The forces generated by striated muscles are considerably greater than those of most other cells. It is easy to envisage how there may be a need for an integrin with a unique cytoplasmic domain to transmit this higher tension across the muscle membrane. The restricted distribution of 131D and its enrichment at myotendinous junctions and costameres, which represent major force transmission sites in skeletal muscle, are consistent with such a function. Like 131D, several components of the peripheral membrane cytoskeleton are expressed only in muscle tissues. These include dystrophin, syntrophin and aciculin (Froehner et al., 1987; Hoffman et al., 1987; Watkins et al., 1988; Campbell, 1991, 1993; Sealock et al., 1991; Porter et al., 1992; Straub et al., 1992; Adams et al., 1993; Yang et al., 1994; Burridge, 1994, 1995) . One mode of attachment of dystrophin to the sarcolemma involves a non-integrin ECM receptor dystroglycan Campbell, 1991, 1993; Ibraghimov-Beskrovnaya et al., 1992) . However, additional linkages may also be involved and it will be important to explore whether the 131D cytoplasmic domain binds to dystrophin or other unique components of the subsarcolemmal cytoskeleton. With most integrins, the interactions with ECM ligands, as well as with cytoskeletal proteins, involves relatively low affinities Otey et al., 1990; Hynes, 1992) . Presumably these are sufficient for the necessary anchorage and traction of most cells, without precluding the remodeling that must occur during cell migration. With striated muscles the requirements are different. Mature muscle cells do not migrate and, as mentioned above, the tensile forces that have to be transmitted are high. Consequently, high affinity interactions involving integrins may be both tolerated and desirable. One possibility is that the unique cytoplasmic sequence of the [31D integrin subunit increases the affinity of 131D integrin heterodimers for cytoskeletal or both cytoskeletal and extracellular ligands. We hope to test this possibility in our future work.
